Zevra Therapeutics (ZVRA) EV to EBIT (2021 - 2026)
Zevra Therapeutics' EV to EBIT came in at 5.08 for Q3 2026, down 33.5% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) EV to EBIT (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Zevra Therapeutics reported EV to EBIT of -1.74; for FY2021, it came in at 64.36.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.08 |
| Jun 30, 2026 | 7.64 |
| Dec 31, 2021 | 64.36 |
| Sep 30, 2021 | 71.70 |
| Jun 30, 2021 | 91.39 |
| Mar 31, 2021 | 53.92 |
API Access
Zevra Therapeutics EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();